Funded Tech Companies

Larkspur Biosciences

Researching who backed Larkspur Biosciences? Takeda Ventures, Polaris Partners and 3E Bioventures joined the equity holders in this biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

Larkspur was founded to develop precision immunotherapies targeting the key intersection between the tumor and the immune system. Our science is based on discoveries by our founders that the genetic deficiency of specific targets leads to autoimmunity -- a hallmark of targets that are important for cancer immunotherapy. With a proven track record of drug discovery and development, our team is passionate about solving hard problems and driven to deliver new medicines to cancer patients with significant unmet needs.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

5/24/2023

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Catherine Peyton

        

Chief Scientific Officer

Krista Goodman

        

Company Investors

• Takeda Ventures
• Polaris Partners
• 3E Bioventures
• Med-Fine Capital
• Creacion Ventures
• Cornell University

Browse more funded tech companies:

Lark Health | Larky

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary